anal GLIDE

Dosage form: gel
Ingredients: BENZOCAINE 2833mg in 60mL
Labeler: Product Max Group Inc
NDC code: 70742-092

Medically reviewed by Drugs.com. Last updated on Jul 31, 2023.

anal GLIDE - 092

Drug Facts
Active Ingredient

Benzocaine 5%

Purpose

Topical Analgesic

Keep out of reach of children

Keep out of reach of children.

If swallowed get medical help or contact a Poison Control Center right away.

Uses

For temporary relief of pain or soreness in the perianal area.

Warnings

For external use only.

Avoid contact with eyes.
Certain persons can develop allergic reactions from ingredients in this product. If the symptom being treated goes not subside or if redness, irritation, swelling, pain or other symptoms develop or increase, discontinue use and consult a doctor.

Directions

When practical, cleanse the affected area with mild soap and warm water and rinse thoroughly.
Gently dry by patting or blotting with toilet tissue or a soft cloth before application of this product.
Apply to the affected area up to 6 times daily.

Other Information

Do not use if safety seal is broken or missing.

Inactive Ingredients

Hydroxyethylcellulose, Methylparaben, PEG-8, Propylene Glycol, Propylparaben, Water

anal GLIDE EXTRA product label

anal GLIDE EXTRA

Desensitizer Lubricating Gel

PREMIUM

Benzocaine Anorectal Gel

Anal Desensitizer

2 FL OZ (60 ml)

www.bodyactionproducts.com

Distributed by:

Body Action Products

Lutz, FL 33559

ACTION BODY PRODUCTS

ANAL GLIDE
benzocaine gel

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:70742-092
Route of Administration	TOPICAL	DEA Schedule

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
BENZOCAINE (BENZOCAINE)	BENZOCAINE	2833 mg in 60 mL

Inactive Ingredients
Ingredient Name	Strength
HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%)
METHYLPARABEN
POLYETHYLENE GLYCOL 400
PROPYLENE GLYCOL
PROPYLPARABEN
WATER

Packaging
#	Item Code	Package Description
1	NDC:70742-092-01	60 mL in 1 BOTTLE, PUMP

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph final	part348	06/15/2016

Labeler - Product Max Group Inc (134893911)

Registrant - Product Max Group Inc (134893911)

Document Id: bd0dd8a9-3d50-4b11-bed0-28e5efc99fb7

Set id: 55ac41c4-c0ff-4846-9a6f-39aedbe7d545

Version: 1

Effective Time: 20160808

Product Max Group Inc

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer